Dr. Amy Moore serves as LUNGevity Foundation’s Vice President of Global Engagement and Patient Partnerships. She is a PhD-trained virologist and cancer researcher who has spent over a decade working on large-scale initiatives to build research capacity and improve cancer outcomes. In her role with LUNGevity, Dr. Moore is working to strengthen collaborations with international partners, particularly in the areas of biomarker testing and precision medicine as well as in improving access to clinical trials, so that all patients receive optimal cancer care no matter where they live. Given her background in virology, Dr. Moore has also been a sought-after expert throughout the pandemic on issues at the intersection of COVID-19 and lung cancer and is part of a large NCI-funded grant to study the quality of the immune response to SARS-CoV-2 infection and vaccination among patients with lung cancer. Dr. Moore serves on a number of advisory boards and frequently presents at major national and international conferences.